Dynamic Incorporation of Histone H3 Variants into Chromatin Is Essential for Acquisition of Aggressive Traits and Metastatic Colonization
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Summary Metastasis is the leading cause of cancer mortality. Chromatin remodeling provides the foundation for the cellular reprogramming necessary to drive metastasis. However, little is known about the nature of this remodeling and its regulation. Here, we show that metastasis-inducing pathways regulate histone chaperones to reduce canonical histone incorporation into chromatin, triggering deposition of H3.3 variant at the promoters of poor-prognosis genes and metastasis-inducing transcription factors. This specific incorporation of H3.3 into chromatin is both necessary and sufficient for the induction of aggressive traits that allow for metastasis formation. Together, our data clearly show incorporation of histone variant H3.3 into chromatin as a major regulator of cell fate during tumorigenesis, and histone chaperones as valuable therapeutic targets for invasive carcinomas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091 · cited 4×
“, 1999; Samatar and Poulikakos, 2014), and metastasis inducing signals often result in the activation of ERK (Janda et al., 2002; Lamouille et al., 2014).”
BackgroundInfluentialGene ontology analysis for RNA-seq: accounting for selection bias
Young, M. D., Wakefield, M. J., Smyth, G. K., & Oshlack, A. (2010) · Genome Biology · doi:10.1186/gb-2010-11-2-r14 · Cited by 7,107
Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y., & Greenleaf, W. J. (2013) · Nature Methods · doi:10.1038/nmeth.2688 · Cited by 6,422
Elias, J. E., & Gygi, S. P. (2007) · Nature Methods · doi:10.1038/nmeth1019 · Cited by 3,925
Capturing Chromosome Conformation
Dekker, J., Rippe, K., Dekker, M., & Kleckner, N. (2002) · Science · doi:10.1126/science.1067799 · Cited by 3,652 · cited 1×
“A tightly packaged chromatin structure reduces access to DNA and limits gene expression and genomic instability, while an open chromatin structure promotes gene expression and genomic instability (Dekker et al., 2002; Hendrich and Willard, 1995).”
BackgroundTransitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Polyak, K., & Weinberg, R. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2620 · Cited by 3,302 · cited 3×
“Consistent with the morphological changes resembling EMT, knockdown of CAF-1 was sufficient to promote an increase in the mesenchymal marker fibronectin and a decline in the epithelial marker E-cadherin (Figures 4A, 4C and S4B–S4D) (Lamouille et al., 2014; Polyak and Weinberg, 2009).”
BackgroundGenes that mediate breast cancer metastasis to lung
Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922 · cited 5×
“Lung Colonization in Mice—Luciferase-expressing MDA-MB-231 parental cells (less metastatic) and LM2 cells (more metastatic) (Minn et al., 2005) were utilized for these experiments.”
BackgroundMethodInfluentialSelf-citationTargeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
Roberts, P. J., & Der, C. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210422 · Cited by 2,788 · cited 1×
“Although several drugs have shown promising short-term results in the treatment of certain cancers, the emergence of drug resistance upon long-term treatments has severely impacted their use as effective cancer therapies (Roberts and Der, 2007; Samatar and Poulikakos, 2014).”
BackgroundAn improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues
Corces, M. R., Trevino, A. E., Hamilton, E. G., Greenside, P. G., Sinnott-Armstrong, N. A., Vesuna, S., Satpathy, A. T., Rubin, A. J., Montine, K. S., Wu, B., et al. (2017) · Nature Methods · doi:10.1038/nmeth.4396 · Cited by 2,496
Chromatin modification and epigenetic reprogramming in mammalian development
Li, E. (2002) · Nature Reviews Genetics · doi:10.1038/nrg887 · Cited by 1,900
A tissue-specific atlas of mouse protein phosphorylation and expression
Huttlin, E. L., Jedrychowski, M. P., Elias, J. E., Goswami, T., Rad, R., Beausoleil, S. A., Villén, J., Haas, W., Sowa, M. E., & Gygi, S. P. (2010) · Cell · doi:10.1016/j.cell.2010.12.001 · Cited by 1,778 · cited 2×
“Peptide spectral matches (PSMs) were filtered to 1% FDR using the target-decoy strategy (Elias and Gygi, 2007) combined with linear discriminant analysis (LDA) (Huttlin et al., 2010) using several different parameters including Xcorr, ∆Cn’, precursor mass error, observed ion charge state, and predicted solution charge…”
MethodTargeting RAS–ERK signalling in cancer: promises and challenges
Samatar, A. A., & Poulikakos, P. I. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4281 · Cited by 1,163
Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs
Oskarsson, T., Acharyya, S., Zhang, X. H.-F., Vanharanta, S., Tavazoie, S. F., Morris, P. G., Downey, R. J., Manova-Todorova, K., Brogi, E., & Massagué, J. (2011) · Nature Medicine · doi:10.1038/nm.2379 · Cited by 869 · cited 1×
“Lung colonization was evaluated as described before (Minn et al., 2005; Oskarsson et al., 2011).”
MethodSelf-citationHistone H3.3 is enriched in covalent modifications associated with active chromatin
McKittrick, E., Gafken, P. R., Ahmad, K., & Henikoff, S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308092100 · Cited by 520 · cited 1×
“Considering the growing body of evidence showing that chromatin accessibility by transcriptional machinery is heavily influenced by histone variants (Hu et al., 2013; McKittrick et al., 2004; Venkatesh and Workman, 2015), we hypothesized that histone H3 variants are differentially regulated during tumor progression to…”
Elevated histone expression promotes life span extension
Feser, J., Truong, D., Das, C., Carson, J. J., Kieft, J., Harkness, T., & Tyler, J. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.08.015 · Cited by 435 · cited 1×
“Although unanticipated, the loss of canonical histones has been observed in other pathological conditions, such as aging, and shown to be causal (Feser et al., 2010).”
BackgroundSelf-citationEr, E. E., Valiente, M., Ganesh, K., Zou, Y., Agrawal, S., Hu, J., Griscom, B., Rosenblum, M., Boire, A., Brogi, E., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0138-8 · Cited by 292
Self-citationA pipeline for the generation of shRNA transgenic mice
Dow, L. E., Premsrirut, P. K., Zuber, J., Fellmann, C., McJunkin, K., Miething, C., Park, Y., Dickins, R. A., Hannon, G. J., & Lowe, S. W. (2012) · Nature Protocols · doi:10.1038/nprot.2011.446 · Cited by 159 · cited 1×
“3, lentiviruses targeting H3F3A, H3F3B, and Luciferase (control) were produced using doxycycline-inducible mirE-based shRNA constructs (Dow et al., 2012) obtained from the RNAi Core facility at Memorial Sloan Kettering Cancer Center (New York, NY).”
MethodQuivy, J.-P., Gérard, A., Cook, A. J. L., Roche, D., & Almouzni, G. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1470 · Cited by 148 · cited 1×
“Previous studies in cultured cells have long suggested that the major function of CAF-1 is to facilitate cell cycle progression by incorporating the canonical H3/H4 into chromatin during S-phase specific chromatin duplication (Quivy et al., 2008; Smith and Stillman, 1989; Ye et al., 2003).”
BackgroundSpatially Separate Docking Sites on ERK2 Regulate Distinct Signaling Events In Vivo
Dimitri, C. A., Dowdle, W., MacKeigan, J. P., Blenis, J., & Murphy, L. O. (2005) · Current Biology · doi:10.1016/j.cub.2005.06.037 · Cited by 114
Self-citation
Cited by
Ganesh, K., & Massagué, J. (2021) · Nature Medicine · doi:10.1038/s41591-020-01195-4 · Cited by 1,051
Self-citationThe roles of histone variants in fine-tuning chromatin organization and function
Martire, S., & Banaszynski, L. A. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0262-8 · Cited by 392
Metastasis-Initiating Cells and Ecosystems
Massagué, J., & Ganesh, K. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0010 · Cited by 372
Self-citationAltered propionate metabolism contributes to tumour progression and aggressiveness
Gomes, A. P., Ilter, D., Low, V., Drapela, S., Schild, T., Mullarky, E., Han, J., Elia, I., Broekaert, D., Rosenzweig, A., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00553-5 · Cited by 104
Self-citation
Metadata
- Authors
- Gomes, A. P., Ilter, D., Low, V., Rosenzweig, A., Shen, Z.-J., Schild, T., Rivas, M. A., Er, E. E., McNally, D. R., Mutvei, A. P., Han, J., Ou, Y.-H., Cavaliere, P., Mullarky, E., Nagiec, M., Shin, S., Yoon, S.-O., Dephoure, N., Massagué, J., Melnick, A. M., Cantley, L. C., Tyler, J. K., & Blenis, J.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2019-10
- Volume
- 36
- Issue
- 4
- Pages
- 402-417.e13
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2975233555
- Cited by
- 106
- References
- 21
- FWCI
- 3.51
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.